Document is current

Article History

Received: 6 July 2023

Revised: 28 August 2023

Accepted: 15 September 2023

First Online: 8 November 2023

Declarations

:

: The scientific guarantor of this publication is Per Skaane.

: The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.

: One of the authors (Bjørn Helge Østerås) has significant statistical expertise.

: Written informed consent was obtained from all subjects (patients) in this study.

: Institutional Review Board approval was obtained.

: Some study subjects or cohorts have been previously reported in:Skaane P, et al Radiology 2013;267(1):47–56 [ref. ]Skaane P, et al Eur Radiol 2013;23(8):2061–2071 [ref. ]Skaane P, et al Radiology 2014;271(3):655–663 [ref. ]Skaane P, et al Breast Cancer Res Treat 2018;169(3):489–496 [ref. ]Skaane P, et al Radiology 2019;291:23–30 [ref. ]Østerås BH, et al Radiology 2019;293:60–68 [ref. ]We have listed these references in “” (“OTST results have been previously reported [–]”). This article presents unpublished data from the OTST, and in addition, results from a retrospective reader study of the false-negative and interval cancer cases not earlier published.

: • prospective• diagnostic or prognostic study• performed at one institution